The founder of Groupon and one of Chicago’s most influential figures, Eric Lefkofsky has donated a lot of money to cancer research within his lifetime. Recently he has started a new and smarter approach to fight against cancer and it’s damaging effects towards the human race. After leaving his role as a CEO for Groupon, he has been working non-stop on a new startup called Tempus. This new health Tech startup has quietly been working in the background to build a new infrastructure for cancer treatment. Even though his involvement isn’t very clear in regards of Tempus, his website states that he is helping doctors analyze a patient’s genetic code to assist in the curing process. This new cutting-edge therapy analysis will help the doctors understand a patient’s tumor more efficiently.
The new startup collects the information and data using statistical algorithms to uncover a more personalized medicine for their patients. Tempus is used primarily to help doctors create a better care for treatment. Tempus is working with all types of patients. Currently they are assisting patients with lung, breast, and pancreatic cancer. However, in the near future they will tackle more types.
By searching online, you can determine that there are a total of 29 employees. However, this is only an estimate and has not yet been verified. Hunter Lane, the former director of Highground, lists himself as the director of Tempus as well. Eric and his wife Liz are known for their generous contributes to cancer research. They currently have a family foundation that has dedicated over 1 million to the Cancer Center of Northwestern University. They have also donated $500,000 to support gastric cancer research at Stanford University.This is only a couple of the foundations that they have donated funds towards to help families dealing with cancer patients.
In July, Eric Lefkofsky wrote about artificial intelligence and how it is moving forward and will one day be used as a form of Health Care and treatment. He believes this because we have a large database of unmined molecular data that can contribute to the artificial intelligence attribution. Even though he did not mention Tempus and it’s connection, we can conclude from his personal blog that Tempus is a scientific breakthrough worth mentioning.